The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global BioPharma Cold Chain Packaging Market Research Report 2024
Synopsis
Packaging of products is the process of enclosing them for the purpose of their distribution, storage, sale, and use. Packaging also helps advertise a product in a better way and protect it from damage during transportation. Biopharma products are called as biological medical products, such as blood or blood components, vaccines, and tissues. These products require packaging to ensure their safety during transportation, to maintain sterility, and to prevent breakage or spillage and contamination.
The global BioPharma Cold Chain Packaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for BioPharma Cold Chain Packaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BioPharma Cold Chain Packaging.
Report Scope
The BioPharma Cold Chain Packaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global BioPharma Cold Chain Packaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BioPharma Cold Chain Packaging companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amcor
CCL
Clondalkin
Gerresheimer
Segment by Type
Metal Packaging
Glass Packaging
Segment by Application
Blood Components
Vaccines
Tissues
Cells
Stem Cells
Infectious Substances
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of BioPharma Cold Chain Packaging companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Packaging of products is the process of enclosing them for the purpose of their distribution, storage, sale, and use. Packaging also helps advertise a product in a better way and protect it from damage during transportation. Biopharma products are called as biological medical products, such as blood or blood components, vaccines, and tissues. These products require packaging to ensure their safety during transportation, to maintain sterility, and to prevent breakage or spillage and contamination.
The global BioPharma Cold Chain Packaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for BioPharma Cold Chain Packaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BioPharma Cold Chain Packaging.
Report Scope
The BioPharma Cold Chain Packaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global BioPharma Cold Chain Packaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BioPharma Cold Chain Packaging companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amcor
CCL
Clondalkin
Gerresheimer
Segment by Type
Metal Packaging
Glass Packaging
Segment by Application
Blood Components
Vaccines
Tissues
Cells
Stem Cells
Infectious Substances
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of BioPharma Cold Chain Packaging companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global BioPharma Cold Chain Packaging Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Metal Packaging
1.2.3 Glass Packaging
1.3 Market by Application
1.3.1 Global BioPharma Cold Chain Packaging Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Blood Components
1.3.3 Vaccines
1.3.4 Tissues
1.3.5 Cells
1.3.6 Stem Cells
1.3.7 Infectious Substances
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global BioPharma Cold Chain Packaging Market Perspective (2019-2030)
2.2 BioPharma Cold Chain Packaging Growth Trends by Region
2.2.1 Global BioPharma Cold Chain Packaging Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 BioPharma Cold Chain Packaging Historic Market Size by Region (2019-2024)
2.2.3 BioPharma Cold Chain Packaging Forecasted Market Size by Region (2025-2030)
2.3 BioPharma Cold Chain Packaging Market Dynamics
2.3.1 BioPharma Cold Chain Packaging Industry Trends
2.3.2 BioPharma Cold Chain Packaging Market Drivers
2.3.3 BioPharma Cold Chain Packaging Market Challenges
2.3.4 BioPharma Cold Chain Packaging Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top BioPharma Cold Chain Packaging Players by Revenue
3.1.1 Global Top BioPharma Cold Chain Packaging Players by Revenue (2019-2024)
3.1.2 Global BioPharma Cold Chain Packaging Revenue Market Share by Players (2019-2024)
3.2 Global BioPharma Cold Chain Packaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by BioPharma Cold Chain Packaging Revenue
3.4 Global BioPharma Cold Chain Packaging Market Concentration Ratio
3.4.1 Global BioPharma Cold Chain Packaging Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by BioPharma Cold Chain Packaging Revenue in 2023
3.5 BioPharma Cold Chain Packaging Key Players Head office and Area Served
3.6 Key Players BioPharma Cold Chain Packaging Product Solution and Service
3.7 Date of Enter into BioPharma Cold Chain Packaging Market
3.8 Mergers & Acquisitions, Expansion Plans
4 BioPharma Cold Chain Packaging Breakdown Data by Type
4.1 Global BioPharma Cold Chain Packaging Historic Market Size by Type (2019-2024)
4.2 Global BioPharma Cold Chain Packaging Forecasted Market Size by Type (2025-2030)
5 BioPharma Cold Chain Packaging Breakdown Data by Application
5.1 Global BioPharma Cold Chain Packaging Historic Market Size by Application (2019-2024)
5.2 Global BioPharma Cold Chain Packaging Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America BioPharma Cold Chain Packaging Market Size (2019-2030)
6.2 North America BioPharma Cold Chain Packaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America BioPharma Cold Chain Packaging Market Size by Country (2019-2024)
6.4 North America BioPharma Cold Chain Packaging Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe BioPharma Cold Chain Packaging Market Size (2019-2030)
7.2 Europe BioPharma Cold Chain Packaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe BioPharma Cold Chain Packaging Market Size by Country (2019-2024)
7.4 Europe BioPharma Cold Chain Packaging Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific BioPharma Cold Chain Packaging Market Size (2019-2030)
8.2 Asia-Pacific BioPharma Cold Chain Packaging Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific BioPharma Cold Chain Packaging Market Size by Region (2019-2024)
8.4 Asia-Pacific BioPharma Cold Chain Packaging Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America BioPharma Cold Chain Packaging Market Size (2019-2030)
9.2 Latin America BioPharma Cold Chain Packaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America BioPharma Cold Chain Packaging Market Size by Country (2019-2024)
9.4 Latin America BioPharma Cold Chain Packaging Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa BioPharma Cold Chain Packaging Market Size (2019-2030)
10.2 Middle East & Africa BioPharma Cold Chain Packaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa BioPharma Cold Chain Packaging Market Size by Country (2019-2024)
10.4 Middle East & Africa BioPharma Cold Chain Packaging Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amcor
11.1.1 Amcor Company Detail
11.1.2 Amcor Business Overview
11.1.3 Amcor BioPharma Cold Chain Packaging Introduction
11.1.4 Amcor Revenue in BioPharma Cold Chain Packaging Business (2019-2024)
11.1.5 Amcor Recent Development
11.2 CCL
11.2.1 CCL Company Detail
11.2.2 CCL Business Overview
11.2.3 CCL BioPharma Cold Chain Packaging Introduction
11.2.4 CCL Revenue in BioPharma Cold Chain Packaging Business (2019-2024)
11.2.5 CCL Recent Development
11.3 Clondalkin
11.3.1 Clondalkin Company Detail
11.3.2 Clondalkin Business Overview
11.3.3 Clondalkin BioPharma Cold Chain Packaging Introduction
11.3.4 Clondalkin Revenue in BioPharma Cold Chain Packaging Business (2019-2024)
11.3.5 Clondalkin Recent Development
11.4 Gerresheimer
11.4.1 Gerresheimer Company Detail
11.4.2 Gerresheimer Business Overview
11.4.3 Gerresheimer BioPharma Cold Chain Packaging Introduction
11.4.4 Gerresheimer Revenue in BioPharma Cold Chain Packaging Business (2019-2024)
11.4.5 Gerresheimer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
